Direct-to-consumer drug ads have long blurred the line between patient empowerment and corporate persuasion, but the FDA is ...

Ichor has grown revenue at a 12.6% CAGR, driven mainly by acquisitions, but struggles to convert growth into lasting profitability. Read why ICHR stock is a Hold.

This professional analysis covers accounting, tax, and reporting issues for virtual assets in India, including classification, revenue recognition, tax implications under Section 115BBH, and ...

Physicians and other healthcare leaders must have the foresight and integrity to implement AI in ways that honor their ...

Research suggests the key is to make lectures more personal, experiential, engaging and interactive.